Sewoon Medical Co., Ltd (KOSDAQ: 100700)

Sewoon Medical Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Other Revenue	-0	-0	-	-	-0	-
Revenue	64,875	68,247	60,116	62,579	63,729	66,869
Revenue Growth (YoY)	0.28%	13.53%	-3.94%	-1.80%	-4.69%	5.94%
Cost of Revenue	38,866	40,689	37,896	37,522	40,005	39,441
Gross Profit	26,009	27,557	22,220	25,057	23,725	27,428
Selling, General & Admin	9,571	9,330	8,734	8,466	8,344	9,697
Research & Development	502.68	468.21	505.09	427.87	321.38	340.23
Operating Expenses	10,908	10,637	10,033	9,671	9,828	10,520
Operating Income	15,101	16,920	12,187	15,386	13,897	16,908
Interest Expense	-31.96	-36.08	-35.81	-31.47	-31.63	-58.12
Interest & Investment Income	2,141	1,969	736.18	172.83	133.32	168.56
Currency Exchange Gain (Loss)	684.34	357.41	702.87	1,035	-578.91	60.36
Other Non Operating Income (Expenses)	61.25	69.67	38.25	67.05	159.15	148.63
EBT Excluding Unusual Items	17,956	19,280	13,629	16,630	13,579	17,227
Gain (Loss) on Sale of Assets	16.99	17.79	2.2	-0.67	-8.81	3.7
Asset Writedown	-	-	-2	-2.96	-233.53	-
Pretax Income	17,973	19,298	13,629	16,626	13,337	17,231
Income Tax Expense	3,375	3,824	2,990	3,864	2,782	2,755
Earnings From Continuing Operations	14,598	15,474	10,639	12,762	10,555	14,476
Earnings From Discontinued Operations	-	-	-	-	286.25	-4,497
Net Income to Company	14,598	15,474	10,639	12,762	10,841	9,979
Minority Interest in Earnings	-453.44	-517.02	-232.69	-480.5	-345.26	-502.74
Net Income	14,145	14,957	10,406	12,282	10,496	9,476
Net Income to Common	14,145	14,957	10,406	12,282	10,496	9,476
Net Income Growth	11.18%	43.73%	-15.27%	17.02%	10.76%	-2.03%
Shares Outstanding (Basic)	43	43	43	43	43	43
Shares Outstanding (Diluted)	43	43	43	43	43	43
Shares Change (YoY)	0.25%	-	-	-	-	-
EPS (Basic)	326.33	345.50	240.38	283.70	242.44	218.89
EPS (Diluted)	326.33	345.50	240.38	283.70	242.44	218.89
EPS Growth	10.91%	43.73%	-15.27%	17.02%	10.76%	-2.03%
Free Cash Flow	15,145	21,127	7,128	19,244	16,978	7,547
Free Cash Flow Per Share	349.41	488.02	164.65	444.53	392.19	174.32
Dividend Per Share	70.000	70.000	60.000	50.000	50.000	50.000
Dividend Growth	16.67%	16.67%	20.00%	0%	0%	0%
Gross Margin	40.09%	40.38%	36.96%	40.04%	37.23%	41.02%
Operating Margin	23.28%	24.79%	20.27%	24.59%	21.81%	25.29%
Profit Margin	21.80%	21.92%	17.31%	19.63%	16.47%	14.17%
Free Cash Flow Margin	23.35%	30.96%	11.86%	30.75%	26.64%	11.29%
EBITDA	18,641	20,568	16,075	19,222	17,581	20,405
EBITDA Margin	28.73%	30.14%	26.74%	30.72%	27.59%	30.52%
D&A For EBITDA	3,540	3,648	3,888	3,836	3,684	3,497
EBIT	15,101	16,920	12,187	15,386	13,897	16,908
EBIT Margin	23.28%	24.79%	20.27%	24.59%	21.81%	25.29%
Effective Tax Rate	18.78%	19.82%	21.94%	23.24%	20.86%	15.99%
Advertising Expenses	-	233.54	186.34	76.21	29.71	342.58

Source: S&P Capital IQ. Standard template. Financial Sources.